Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, 7SL, cytoplasmic 75, pseudogene (RN7SL75P)** is classified as a pseudogene in the human genome[6][7]. It belongs to a large family of 7SL RNA–like sequences that do not code for functional RNA and are the result of reverse transcription of the 7SL RNA gene back into DNA, often truncating at either end or in the middle[7]. Pseudogenes like RN7SL75P lack coding potential and biological activity; they do not code for proteins or functional RNAs and have no known physiological or pathological roles in humans[4][7]. They are not considered molecular targets for therapeutics, biomarkers, or clinical diagnostics. **Notes on Target Validity:** RN7SL75P is **not** a functional gene or molecule and is consequently **not considered a molecular target** for drugs or diagnostics. Being a pseudogene means it is a remnant of a functional gene, usually with lost or severely diminished function[4][7]. No interacting drugs, mechanism of action, or disease relevance are known for RN7SL75P. **Other Context:** The canonical, functional version of 7SL RNA (not the pseudogenes) is a critical component of the signal recognition particle, involved in co-translational targeting of secretory and membrane proteins, but RN7SL75P does not have these functions[1][3]. There are hundreds of such 7SL RNA–like pseudogenes in the human genome; RN7SL75P is one example without demonstrated biological activity[7][6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 75, pseudogene (RN7SL75P).